Lactulosa Biomedica

Lactulose, the active ingredient in Lactulosa Biomedica, is an osmotic laxative presented as an oral solution for oral use. It is employed to relieve constipation and to manage hepatic encephalopathy in patients with liver disease, helping to reduce blood ammonia levels.

GNH USA supplies Lactulosa Biomedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The company maintains rigorous quality control and provides reliable logistics for timely delivery.

Lactulose is an osmotic laxative used to treat conditions related to bowel motility and ammonia accumulation.

- Constipation: softens stool and promotes regular bowel movements. - Hepatic encephalopathy: lowers colonic ammonia absorption, improving mental status in liver disease patients. - Hyperammonemia: reduces elevated blood ammonia levels, supporting metabolic balance.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas production. - Diarrhea: loose, watery stools. - Stomach cramps: intermittent abdominal pain. - Nausea: sensation of unease and urge to vomit. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal levels of sodium, potassium, or magnesium. - Dehydration: excessive loss of body water. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: persistent, intense pain requiring medical attention.

Before initiating lactulose therapy, consider the following safety measures.

- Renal function assessment: evaluate kidney health to avoid accumulation of metabolites. - Electrolyte monitoring: check sodium, potassium, and magnesium levels during treatment. - Diabetes caution: monitor blood glucose as lactulose contains fermentable sugars. - Intestinal obstruction avoidance: do not use in patients with known bowel blockage. - Discontinuation guidance: taper gradually under medical supervision to prevent rebound constipation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can interact with other medications, altering its efficacy or safety.

Major Interactions (Avoid): - Antidiarrheal agents (e.g., loperamide): may reduce lactulose's laxative effect. - Insulin or oral hypoglycemics: carbohydrate content can potentiate hypoglycemia.

Moderate Interactions (Monitor Closely): - Magnesium‑containing supplements: may enhance osmotic activity and cause diarrhea. - Broad‑spectrum antibiotics: can alter colonic flora, affecting lactulose metabolism. - Probiotic preparations: may modify bacterial conversion of lactulose, influencing efficacy.